Eiger BioPharmaceuticals (EIGR) Competitor Comparison
We are evaluating the key criteria listed to compare Eiger BioPharmaceuticals (EIGR) against its competitors in the Biotechnology industry.
Market Capitalization
347 / 368Gross Profits
98 / 278Total Revenue
171 / 300EBITDA
183 / 337Free Cashflow
222 / 352Quick Ratio
264 / 357Earnings per Share
355 / 359Dividend yield
0 / 6Total Cash
264 / 358Performance 3 years
342 / 368Performance 5 years
343 / 368Performance 10 years
348 / 368Linearity 3 years
210 / 368Linearity 5 years
201 / 368Linearity 10 years
304 / 368Total Rank
114 / 368Dividend Rank
116 / 368Valuation Rank
57 / 368Piotroski Rank
228 / 368Muliplier Rank
337 / 368Linearity 3 years - EIGR ranking 210 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.